In Philadelphia, the parents of a cancer-stricken five-year-old boy are suing the insurance company HealthAmerica for refusing to cover medical treatment that could prolong their son’s life. The boy, Kyler VanNocker, suffers from the rare childhood cancer neuroblastoma. HealthAmerica is refusing to pay for treatment known as MIBG, because it’s “investigational/experimental” and its effectiveness hasn’t been clinically proven. HealthAmerica had previously covered treatments that didn’t meet the same criteria and ended up helping save Kyler’s life. The hospital where Kyler is being treated has provided the MIBG treatment for free in the hopes HealthAmerica will reverse its stance or Medicaid will cover the costs. The VanNockers say the treatment has improved Kyler’s health and may even have eliminated some of his tumors.